ask="100.00"
ask_size="200"
average_daily_volume="430972"
bid="N/A"
bid_size="N/A"
book_value="11.49"
change="-1.75"
change_from_200_day_moving_average="11.51"
change_from_50_day_moving_average="6.60"
change_from_52_week_high="-7.12"
change_From_52_week_low="37.70"
change_in_percent="-2.04%"
close="84.22"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.00"
ex_dividend_date="N/A"
float_shares="38575000"
high="85.68"
high_52_weeks="91.35"
last_trade_date="3/13/2017"
last_trade_price="84.22"
last_trade_size="11044"
last_trade_time="4:00pm"
low="84.14"
low_52_weeks="46.52"
market_capitalization="3.51B"
moving_average_200_day="72.71"
moving_average_50_day="77.62"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="85.63"
pe_ratio="N/A"
peg_ratio="-0.41"
percent_change_from_200_day_moving_average="+15.84%"
percent_change_from_50_day_moving_average="+8.51%"
percent_change_from_52_week_high="-7.80%"
percent_change_from_52_week_low="+81.04%"
previous_close="85.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.48"
price_per_sales="26971.31"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="13.64"
stock_exchange="NMS"
symbol="RARE"
volume="269361"
weeks_range_52="46.52 - 91.35"
